Equities

Charles River Laboratories International Inc

Charles River Laboratories International Inc

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (USD)120.10
  • Today's Change0.150 / 0.13%
  • Shares traded92.10k
  • 1 Year change20.47%
  • Beta0.6288
Data delayed at least 15 minutes, as of Jul 18 2018 16:59 BST.
More ▼

Key statistics

Charles River Laboratories International Inc (CRL:NYQ) set a new 52-week high during Tuesday's trading session when it reached 120.51. Over this period, the share price is up 19.94%.
52-week range
Today
94.15Aug 09 2017120.51Jul 17 2018
Markit short selling activity
Low
Med
High
Open120.35
High120.35
Low119.21
Bid120.11
Offer120.22
Previous close119.95
Average volume205.90k
Shares outstanding47.91m
Free float47.13m
P/E (TTM)27.84
Market cap5.75bn USD
EPS (TTM)4.31
USD
Data delayed at least 15 minutes, as of Jul 18 2018 16:59 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.